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Abstract
Homo and heterozygote cx3cr1 mutant mice, which harbor a green fluorescent protein (EGFP) in their cx3cr1 loci,
represent a widely used animal model to study microglia and peripheral myeloid cells. Here we report that
microglia in the dentate gyrus (DG) of cx3cr1−/− mice displayed elevated microglial sirtuin 1 (SIRT1) expression levels
and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) p65 activation, despite unaltered
morphology when compared to cx3cr1+/− or cx3cr1+/+ controls. This phenotype was restricted to the DG and
accompanied by reduced adult neurogenesis in cx3cr1−/− mice. Remarkably, adult neurogenesis was not affected by
the lack of the CX3CR1-ligand, fractalkine (CX3CL1). Mechanistically, pharmacological activation of SIRT1 improved
adult neurogenesis in the DG together with an enhanced performance of cx3cr1−/− mice in a hippocampus-
dependent learning and memory task. The reverse condition was induced when SIRT1 was inhibited in cx3cr1−/−
mice, causing reduced adult neurogenesis and lowered hippocampal cognitive abilities. In conclusion, our data
indicate that deletion of CX3CR1 from microglia under resting conditions modifies brain areas with elevated cellular
turnover independent of CX3CL1.
Keywords: Microglia, Water maze, Morphometry, Adult neurogenesis, Sirtuin 1
Introduction
CX3CR1 is a seven transmembrane domain receptor
coupled to Gi and Gz subtypes of G proteins, activation of
which is linked to several intracellular second messengers
like phosphoinositide 3-kinase (PI3K), protein kinase B
(AKT) and nuclear factor kappa-light-chain-enhancer of
activated B cells (NFkB) [1]. CX3CR1 is prominently
expressed by monocytes, subsets of NK and dendritic
cells, and the brain microglia [2]. Surprisingly little is
known on which intracellular signaling pathways in
microglia are affected by the lack of CX3CR1. Microglial
cells are fundamentally distinct from other brain cells in
that they are derived from primitive myeloid progenitors
that arise during embryogenesis [3–5]. They represent the
resident phagocytic cells in the brain, taking part in
immune-mediated defense mechanisms and clearing cell
debris [6]. Microglial cells are constantly surveying their
surroundings and are implicated in synaptic pruning, dur-
ing both development and throughout adulthood, and
therefore believed to play a role in regulating homeostatic
neuronal synaptic plasticity [7, 8]. Neurons and micro-
glia are thought to communicate with one another
through neuronal expression of the CX3CR1 ligand
CX3CL1 (or fractalkine). CX3CL1 is expressed at the cell
membrane of selected neurons and binds to and activates
CX3CR1 receptors on microglia [9, 10]. CX3CL1 exists in
two distinct forms: a full-length membrane-bound form
and a shed form that contains the N-terminal chemokine
domain. The shed chemokine domain of CX3CL1 acts,
when cleaved, as a signaling molecule and can bind
microglial-expressed CX3CR1 receptors [11], whereas its
membrane-bound mucin stalk can serve as a cell adhesion
molecule [12]. CX3CL1 is abundantly expressed in the
granular cell layer of the rat dentate gyrus (DG), where
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addition of recombinant CX3CL1 reverses age-related de-
cline in adult neurogenesis [13]. Both, cx3cr1−/− and
cx3cr1+/− mice display reduced hippocampal neurogenesis
compared with wild-type controls [13, 14]. However, it is
not clear to what extent CX3CL1 is mandatory for prolif-
eration and neurogenesis. In addition to the already men-
tioned reduced hippocampal neurogenesis, cx3cr1−/− mice
were reported to exhibit excessive hippocampal IL-1β ex-
pression and either enhanced [15] or attenuated long term
potentiation (LTP) [14] resulting in improved [15] or im-
paired cognitive functions [13, 14]. It is important to men-
tion that Maggi et al. were using exclusively female mice
(3 months of age). Rogers et al. and Bachstetter et al. per-
formed all experiments with male mice, 3 months and
4 months of age, respectively. In addition to these conflict-
ing results, little is known about the intracellular signaling
cascades activated by CX3CR1 deficiency, which might
impact synaptic plasticity and cognition. One of these
pathways could include the NF-kB signaling pathway,
which may trigger microglial activation and induce the
release of inflammatory factors including IL-1β, as seen
following irradiation [16], during normal aging [17] or
neurodegeneration [18]. Along these lines, sirtuin 1
(SIRT1), a member of the sirtuin family, might be modu-
lated in microglia by the lack of CX3CR1 because it can
suppress inflammatory responses by inhibiting NF-kB
signaling [19, 20].
Here we investigated the consequences of the microglial
CX3CR1 deletion on cell morphology, activation of the
NF-kB signaling pathway, the expression of SIRT1, inter-
ference with neuroblasts, immature neurons and cogni-
tion. Our findings indicate that, under brain homeostasis,
hippocampal microglia from cx3cr1−/− mice are very simi-
lar, if not identical, to microglia from adult wild-type ani-
mals in contrast to the situation in newborns or during
development. However, hippocampal cx3cr1−/− microglia
show activation of SIRT1 and the NF-kB pathway in areas
of adult neurogenesis. We found that manipulation of
SIRT1 activation in cx3cr1−/− mice directly impacts cogni-
tive performance, while the same treatment had no detect-
able effect on cognition in wild-type littermates.
Materials and methods
This article does not contain any studies with human
participants performed by any of the authors.
Mice
For all animal experiments “Principles of laboratory ani-
mal care” (NIH publication No. 86–23, revised 1985)
were followed. All experiments were approved by the
Federal Ministry for Nature, Environment and Con-
sumers’ Protection of the states of Baden-Württemberg
(G12/71 and G11/50), and were carried out in
accordance to the respective national, federal, and insti-
tutional regulations. Adult, 8–12 weeks old, male mice
were used for the experiments. Mice were group housed
up to five per cage with 12 h light/dark cycle with lights
on at 6 a.m. Food and water were available ad libitum.
cx3cr1gfp/gfp on a C57BL/6 J background were obtained
from the Jackson Laboratory. cx3cl1−/− mice were de-
scribed previously [21]. In all experiments, wild type lit-
termates were used as controls.
Morris Water Maze (MWM) test
The MWM was used to measure spatial learning and
memory [22]. The apparatus consisted of a black plastic
pool with a diameter of 120 cm. A black escape-platform
(square, 10 × 10 cm) was located 1.0 cm below (hidden)
the water surface. The temperature of the water was
kept constant throughout the experiment (20 ± 0.5 °C),
and a 10 min recovery period was allowed between the
training trials. The training consisted of 6 consecutive
days of testing, with four trials per day. If the mouse
failed to find the escape platform within the maximum
time (60 s), the animal was placed on the platform for
10 s by the experimenter. During the first 6 days of test-
ing, the mice were trained with a hidden platform. The
platform location was kept constant, and the starting
position varied between four constant locations at the
pool rim. Mice were placed in the water with their nose
pointing toward the wall at one of the starting points in
a random manner. On the 7th day, the platform was re-
moved, and the mice were allowed to swim for 60 s to
determine their search bias. On testing day 8, mice were
trained to find a visible platform, which had a 10 cm
high pole with a white flag and was changed every trial
to a new position. Timing of the latency to find the vis-
ible platform was started and ended by the experi-
menter. A computer running the BIOBSERVE software
(BIOBSERVE) analyzed all variables of the MWM test.
All behavioral experiments were carried out in a double-
blind fashion and mice were tested in random order.
Mouse treatments
EX527 (cat. no. 2780) was purchased from Tocris
Bioscience (Bristol, UK), dissolved in 4 % DMSO/10 %
cyclodextrin in PBS and administered intraperitoneally
(200 μl, i.p.) at a concentration of 250 ng/μL once daily
for 21 days [23]. Resveratrol (cat. no. R5010, Sigma-
Aldrich, St. Louis, USA) was dissolved in PBS and i.p.
injected once daily over a period of 20 days at a concen-
tration of 2 μg/μL [24].
BrdU injections
Adult mice received two intraperitoneal (i.p.) BrdU-
injections (Sigma-Aldrich, St. Louis, MO, USA, 50 mg/
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kg in 0.9 % NaCl, 8 h apart) over 3 days [25]. Animals
were perfused 3 weeks after the last BrdU injection.
Histology
Histology was performed as described previously [26, 27].
Mice were perfused intracardially with ice-cold PBS,
pH 7.4, and 4 % paraformaldehyde/PBS, pH 7.4. Brains
were removed, postfixed overnight in the same fixative,
and paraffin embedded or frozen at −20 °C. Coronal
sections of 20 μm thickness were cut, deparaffinized in
xylene, and blocked with 10 % goat serum/PBS plus 0.2 %
Triton X-100. 30 μm thick free-floating coronal brain sec-
tions were used from perfusion-fixed frozen brain. Sec-
tions were incubated with primary antibody against: Iba-1
(24 h, dilution 1:500 at 4 °C, cat. no. 019-19741, Wako,
Osaka, Japan) [28] to detect microglia, NeuN (24 h, dilu-
tion 1:200 at 4 °C, cat. no. MAB377, Merck Millipore,
Darmstadt, Germany) [29] to detect neurons, DCX (48 h,
dilution 1:250 at 4 °C, C-18, sc-8066, Santa Cruz Biotech-
nology, Dallas, USA) [30] to detect neuroblasts and imma-
ture neurons, BrdU (24 h, dilution 1:200 at 4 °C, cat. no.
OBT0030, ABD, Serotec, Raleigh, NC, USA) [30] to detect
BrdU incorporation, Lamp2 (24 h, dilution 1:250 at 4 °C,
cat. no. ab13524, Abcam, Cambridge, UK) [28] to label ly-
sosomes and late endosomes, Ki67 (24 h, dilution 1:800 at
4 °C, cat. no. ab15580, Abcam, Cambridge, UK) [31] to de-
tect proliferating cells, CD11b (48 h, dilution 1:200 at 4 °
C, cat. no. ab8878, Abcam, Cambridge, UK) [32] to label
ramified parenchymal microglia, and activated caspase-3
(24 h, dilution 1:100 at 4 °C, cat. no.9661, Cell Signaling
Technology, Danvers, MA, USA) [33], which is involved
in the activation cascade of caspases responsible for
apoptosis execution. As secondary antibodies we used:
Alexa-Fluor-647–conjugated secondary antibody (cat. no.
A31573, Life technologies, Waltham, USA) incubated for
2 h, dilution 1:500, at room temperature, Alexa-Fluor-
568–conjugated secondary antibody (cat. no. A11011, Life
technologies) was incubated at a dilution of 1:500 for 2 h
at 20–22 °C, and Alexa Fluor 488–conjugated secondary
antibody (cat. no. A11008, Life technologies), which was
added with a dilution of 1:500 overnight at 4 °C. Nuclei
were counterstained with 4,6-diamidino-2-phenylindole
(DAPI, cat. no. 236276, Boehringer). Images were either
taken using the BZ-9000 Biorevo microscope (Keyence,
Neu-Isenburg, Germany) or the Olympus FluoView 1000
confocal laser scanning microscope (Olympus, Tokyo,
Japan). Integrated fluorescence intensities were measured
using Image J 1.4 software [34].
Cell quantification
Cells were counted using the optical fractionator, a
method for unbiased stereological analysis. This method
was performed using a computer-assisted image analysis
system, consisting of a Leica DMRB/DIC fluorescence
microscope equipped with a computer-controlled mo-
torized stage, a video camera, and the Stereo Investigator
software (MicroBrightField, Williston, VT). The number
of positive cells throughout the rostrocaudal extent of
the dentate gyrus was counted with a coded one-in-16
series for frozen sections (40 μm). We used a modified
version of the optical fractionator method as reported
previously [35–37]. The total numbers of positive cells
were multiplied by 16 and reported as total number of
cells per dentate gyrus. For immunocytochemical ana-
lysis of paraffin sections (30 μm), serial coronal sections
were collected spanning the rostrocaudal extent of the
hippocampus. For quantification, every 12th section was
selected. Every positive cell was counted on these sec-
tions, and, to obtain the relative total number of cells in
the dentate gyrus, these counts were multiplied by 12 to
account for the sampling frequency [25]. In control ex-
periments we could not detect significant differences in
cell numbers, when samples were quantified by both
quantitation methods.
Three-dimensional reconstruction of microglia
40-μm coronal cryo sections from adult brain tissue
were stained with anti-Iba-1 (cat. no. 019-19741, Wako)
[28] for 48 h (dilution 1:500 at 4 °C), followed by stain-
ing with an Alexa Fluor 488–conjugated secondary anti-
body (cat. no. A11008, Life technologies), which was
added with a dilution of 1:500 overnight at 4 °C. Nuclei
were counterstained with DAPI. Imaging was performed
on an Olympus Fluoview 1000 confocal laser scanning
microscope (Olympus) using a 20× 0.95 NA objective. Z
stacks were imaged with 1.14-μm steps in z direction,
1024 × 1024 pixel resolution were recorded and analyzed
using IMARIS software (Bitplane). Four cortical cells
were reconstructed per analyzed mouse.
Laser microdissection
Microdissection of microglia was performed using a
Zeiss PALM MicroBeam as described previously, with
modification [29]. Fast immunochemistry of serial sec-
tions was performed with CD11b antibodies (Serotec).
Immunostained sections were counterstained with DAPI
to facilitate the identification of individual cells. RNA
was isolated with the Rneasy Micro Plus Kit (Qiagen),
and reverse transcription (RT), preamplification, and
real-time PCR were performed using Applied Biosystems
reagents according to the manufacturer’s recommenda-
tions. The primer pairs were used as described previ-
ously [29].
Microglia isolation and flow cytometry
Adult microglia cells were harvested from dissected hip-
pocampal tissue using density gradient separation and
were prepared as described before [27]. In short, samples
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were stained for CD11b and CD45 (eBioscience, BD
Pharmingen) [4]. Cell suspensions were acquired on a
FACS Canto II (Becton Dickinson) or cell populations
were sorted with a MoFlo Astrios (Beckman Coulter)
and further processed. Data were analyzed using FlowJo
software (Tree Star).
Gene expression analysis
FACS-sorted microglial cell populations were collected
directly in cell lysis buffer and subsequently RNA was
isolated with the Arcturus Pico Pure RNA Isolation Kit
(Life Technologies) according to the manufacturer’s
protocol. Reverse transcription and real-time PCR ana-
lysis were performed using high capacity RNA-to-
cDNA-Kit and Gene Expression Master Mix reagents
(Applied Biosystems) according to the manufacturer’s
recommendations. RT-PCRs were analyzed with a Light-
Cycler 480 (Roche) and carried out as described previ-
ously [26, 38]. The following primers were used: HDAC1:
forward 5′-TCACCATGGCGATGGCGTGG-3′, reverse
5′-TGCCGTCTCGCAGTGGGTAGT-3′; HDAC2: forwa





5′-TGCGTCCACGGATGCACTCA-3′; HDAC 5: forwa










ward 5′-TTGCTGCAGGTGGCTGCTCC-3′, reverse 5′-
CTCGGGCCATGGTTCGCTGG-3′; HDAC11: forward
5′-CAGCCCAGCGGGCATTGTGA-3′, reverse 5′-TCT
GTGCCGAGACGCAGGGA-3′; Sirt1: forward 5′-AGC
TGGGGTTTCTGTCTCCTGTGG-3′, reverse 5′-ACGG
CTGGAACTGTCCGGGAT-3′; Sirt2: forward 5′-CTCG
GCCTCTTCTTGTTTCCGCT-3′, reverse 5′-CGAGTCT
GAATCGGTCCGGCTC-3′; Sirt3: forward 5′-CGCTTG
ACCCTCTAGGCGCC-3′, reverse 5′-CCTTCTCCCAC
CTGTAACACTCCCG-3′; Sirt4: forward 5′-ACGGATG
CATGCACAGAGTCCTG-3′, reverse 5′-GAACACGTC
GCCGTCGGGAG-3′; GAPDH: forward 5′-TCCTGCA
CCACCAACTGCTTAGCC-3′, reverse 5′-GTTCAGCT
CTGGGATGACCTTGCC-3′.
Mice underwent diffusion tensor imaging (DTI) exam-
ination at 1562 × 250 μm3 spatial resolution with a cryo-
genic cooled resonator (CCR) at ultrahigh field (7 T) as
described previously [39, 40]. Diffusion images were ac-
quired along 30 gradient directions plus 5 references
without diffusion encoding with a total acquisition time
of 35 min. Fractional anisotropy (FA) maps were statisti-
cally compared by whole brain-based spatial statistics
(WBSS) at the group level vs. wt controls.
Sirtuin 1 activity assay
To quantify sirtuin 1 (Sirt1) activity, nuclear extracts
from sorted microglia (pooled from hippocampi of three
mice per group) were prepared. Nuclear extracts were
used to measure deacetylase activity of an acetylated his-
tone using Epigenase Universal SIRT Activity/Inhibition
Assay Kit (Epigentek, Farmingdale, NY) [41].
Statistical analysis
Statistical analysis was performed using GraphPad Prism
(GraphPad Software, Version 6.0, La Jolla, USA). In gen-
eral, chosen sample sizes are similar to those reported in
previous publications [38]. All data were tested for nor-
mality applying the Kolmogorov-Smirnov test. If normal-
ity was given, an unpaired t test was applied. If the data
did not meet the criteria of normality, the Mann–Whitney
U test was applied. To test for effects of treatment or
genotype a two-factorial analysis of variance (ANOVA)
with post hoc Bonferroni test or Tukey-Kramer HSD test
was applied. Differences were considered significant when
p < 0.05. Number of animals per group is given as “n”. To
obtain unbiased data, experimental mice were all proc-
essed together by technicians and cell quantifications were
performed blinded by two scientists independently and
separately.
Results
Efficient adult hippocampal neurogenesis relies on the
presence of CX3CR1, but is independent on the presence
of CX3CR1
Newborn cells that are destined to become neurons,
within a few hours after their genesis start to express the
microtubule-associated protein doublecortin (DCX) [42].
The rate of adult hippocampal neurogenesis was deter-
mined from DCX+ cells present in the subgranular zone
(SGZ) of the DG at two months of age as detected by
immunofluorescent stainings. In cx3cr1−/− mice, the
number of DCX+ cells was reduced when compared to
cx3cr1+/+ littermates (Fig. 1a, c). The reduction was ac-
companied by a decrease in the number of BrdU+ cells,
a marker for proliferating cells, and a reduced number
of BrdU+/DCX+ cells in cx3cr1−/− mice (Fig. 1a, b). To
determine, whether the lack of CX3CR1 had an effect on
the differentiation of BrdU+ cells, we performed double
labeling with antibodies against BrdU and the neuronal
marker NeuN (Fig. 1a). Again, the number of BrdU
+/NeuN+ double positive cells was reduced in cx3cr1−/−
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Fig. 1 DCX+ cell numbers in the subgranular zone (SGZ) of the dentate gyrus (DG) are regulated by the fractalkine receptor, CX3CR1, but not by its ligand,
fractalkine, under non-stimulated conditions. a Representative immunofluorescent images of coronal DG sections from cx3cr1+/+ (left) and cx3cr1−/− (right)
mice stained for the neuronal marker NeuN (white), the proliferation marker bromdesoxyuridin (BrdU, green) and DCX (red). b Quantification of the number
of BrdU (p< 0.0001, two-tailed Student’s t-test, cx3cr1+/+ (n= 14) vs. cx3cr1−/− (n= 13)) BrdU+DCX (p= 0.0029, two-tailed Student’s t-test, cx3cr1+/+ (n= 13)
vs. cx3cr1−/− (n= 13)) and BrdU+NeuN (p< 0.0444, two-tailed Student’s t-test, cx3cr1+/+ (n= 10) vs. cx3cr1−/− (n= 10)) positive cells in DG revealed lower
cell numbers in cx3cr1−/− mice than in cx3cr1+/+ mice. Similarly, cx3cr1−/− mice had reduced total numbers of DCX+ (p< 0.0001, two-tailed Student’s t-test,
cx3cr1+/+ (n= 14) vs. cx3cr1−/− (n= 13)) (c) and NeuN+ cells when compared to cx3cr1+/+ controls (p= 0.0048, two-tailed Student’s t-test, cx3cr1+/+ (n= 9) vs.
cx3cr1−/− (n= 9)) (d) even though the overall hippocampal volume was not different in both mouse lines (p= 0.6362, two-tailed Student’s t-test, cx3cr1+/+
(n= 4) vs. cx3cr1−/− (n= 4)) (e). f Representative immunofluorescent images of coronal DG sections from cx3cl1+/+ (left) and cx3cl1−/− (right) mice stained
with antibodies against NeuN (white), BrdU (green) and DCX (red). g In the DG of both mouse strains cell numbers for BrdU, BrdU+DCX and BrdU+NeuN
positive cells where not statistically different. There was further no difference in the cell numbers quantified for DCX+ (h) and NeuN+ cells (i) (p> 0.05, two-
tailed Student’s t-test, cx3cl1+/+ (n= 9) vs. cx3cl1−/− (n= 9)). j 3D-reconstruction of ionized calcium-binding adapter molecule 1 (Iba-1)-labeled microglia from
cx3cr1+/+ (left) and cx3cr1−/− (right) mice localized in the SGZ (top row), granular cell layer (GCL, middle row) and hilus (bottom row) of the DG. There were
no significant morphometric differences in microglia of both mouse lines after quantifying k number of segments, l number of branch points, m process
length and n number of terminal points (p> 0.05, two-tailed Student’s t-test, cx3cr1+/+ (n= 25–31 cells from 4 animals) vs. cx3cr1−/− (n= 31–37 cells from 4
animals)). One representative experiment of two is shown. Bars represent mean ± SEM; n.s., not significant. ***p< 0.001; **p< 0.01; *p< 0.05
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mice compared to cx3cr1+/+ littermates (Fig. 1b), result-
ing in an overall lower number of NeuN+ cells in the
DG (Fig. 1d). The reduced number of NeuN+ cells in the
DG of cx3cr1−/− mice had no impact on the total hippo-
campal volume as determined by MRI (Fig. 1e). Interest-
ingly, DCX+ neuroblast proliferation and differentiation
were identical in cx3cl1+/+ and cx3cl1−/− mice (Fig. 1f-h),
indicating that disturbed signaling between neuronal
CX3CL1 and microglial CX3CR1 was not responsible
for reduced adult neurogenesis in cx3cr1−/− mice. In
line with these findings, we observed in the adult
mice, that ablation of CX3CR1 had no effect on
microglial morphology in the SGZ, granule cell layer
or hilus of the DG as displayed with three-
dimensional morphometric measurements (Fig. 1j-n).
We could further exclude that reduced numbers of
DCX+ cells in cx3cr1−/− mice were due to elevated
microglial phagocytosis because there was no differ-
ence in the percentage of double positive LAMP2
+/Iba1+ microglia or in the number of LAMP2+/Iba1
+/DCX+ cells per DG in cx3cr1+/+ and cx3cr1−/− mice
(Fig. 2a, b). In addition, DCX+ cells showed no differ-
ence in caspase-3-mediated apoptosis as indicated by
similar numbers of active-caspase-3+ cells per dentate
gyrus in both genotypes (Fig. 2c, d).
Cx3cr1−/− microglia show increased sirtuin 1 and NF-kB
signaling locally in the dentate gyrus
CX3CR1 is a Gi-protein coupled receptor, which inhibits
cAMP signaling including the cAMP-dependent protein
kinase A (PKA) [43]. All mammalian histone deacety-
lases (HDACs) possess potential phosphorylation sites
and some of them can be phosphorylated by PKA [44].
The phosphorylation status of HDACs often determines
the degree of transcriptional regulation of their target
genes including their own expression in a negative feed-
back loop as described for HDAC1 [45]. Thus, we set
out to perform a quantitative RT-PCR analysis for ex-
pression of HDACs in microglia obtained by fluores-
cence activated cell sorting (FACS) from hippocampi of
cx3cr1−/− and cx3cr1+/+ mice (Fig. 3a). RT-PCR results
revealed that, from all HDACs analyzed, sirtuin 1
(SIRT1) was highest expressed in cx3cr1−/− microglia
when compared to microglia isolated from cx3cr1+/+
mice (Fig. 3a). When hippocampal brain sections were
stained with antibodies against SIRT1, the strongest sig-
nal was detected in microglia (GFP+) from cx3cr1−/−
mice in the DG, with a gradual decrease in SIRT1
signal strength, when microglia from cx3cr1+/− (GFP+)
and cx3cr1+/+ mice (CD11b+) were analyzed (Fig. 3b,
upper row). Microglial SIRT1 signals were diminished
Fig. 2 Reduced cell number of DCX+ cells in the DG of cx3cr1−/− mice is not due to increased microglial phagocytosis or DCX+ cell apoptosis. a
Representative coronal DG sections from cx3cr1+/+ (a) and cx3cr1−/− mice (b) immunostained for the microglia marker Iba1 (white), the
phagocytosis marker lysosome-associated membrane protein 2 (LAMP2, green) and DCX (red) labeling proliferating cells and young developing
neurons. Quantification of LAMP2+Iba1+ cells (top right) (p = 0.3957, two-tailed Student’s t-test, cx3cr1+/+ (n = 12) vs. cx3cr1−/− (n = 8)) or of Iba1
+DCX+LAMP2+ cells (middle right) (p = 0.1551, two-tailed Student’s t-test, cx3cr1+/+ (n = 8) vs. cx3cr1−/− (n = 8)) showed no significant difference
between both mouse lines. Similar numbers of apoptotic cells were detected by an active caspase 3 marker (white) co-stained with DAPI (blue)
and DCX (red) in the DG of cx3cr1+/+ (c) and cx3cr1−/− mice (d) (p = 0.3406, two-tailed Student’s t-test, cx3cr1+/+ (n = 13) vs. cx3cr1−/− (n = 13)) as
depicted in the bar graph (bottom right). One representative experiment of two is shown. Bars represent mean ± SEM; n.s., not significant
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Fig. 3 Enhanced microglial SIRT1 expression and acetylation of p65 in the DG of cx3cr1−/− mice. Flow cytometric analysis based on cell size and
granularity identified hippocampal microglia from cx3cr1+/+ and cx3cr1−/− mice with CD11bhigh/CD45pos expression (a, FACS blots to the right). No
significant induction of mRNA levels was found for HDAC4-HDAC10 and sirtuin2-sirtuin4 when cx3cr1−/− mRNA levels were divided by mRNA levels
found in cx3cr1+/+ microglia (p > 0.05, two-tailed Student’s t-test, cx3cr1+/+ (n = 6) vs. cx3cr1−/− (n = 6)) (a, bar graph). HDAC1-HDAC3, HDAC11 and
sirtuin1 mRNA levels were significantly higher in hippocampal microglia from cx3cr1−/− mice compared to cx3cr1+/+ mice (a, bar graph). Bars represent
normalized mRNA expression of cx3cr1−/− microglia (n = 6) in fold over cx3cr1+/+ microglia (n = 6, ***p < 0.001; *p < 0.05) (b) Immunostaining of coronal
DG (upper row) and CA1 (lower row) sections from cx3cr1+/+ (left), cx3cr1+/− (middle) and cx3cr1−/− (right) mice for DAPI (blue), Sirt1 (red) and CD11b
(green). In cx3cr1+/− and cx3cr1−/− mice microglia were labeled with GFP (green). In the DG area the integrated Sirt1 fluorescence signal was increased
in cx3cr1+/− microglia compared with the signal found in cx3cr1+/+ microglia (p = 0.0031, two-tailed Student’s t-test, cx3cr1+/+ (n = 4) vs. cx3cr1+/−
(n = 7)) and even more intense in cx3cr1−/− when compared to cx3cr1+/− microglia (p < 0.001, two-tailed Student’s t-test, cx3cr1+/− (n = 6) vs. cx3cr1−/−
(n = 7)). In the CA1 region cx3cr1−/− microglial Sirt1 staining was found to be only slightly increased (p = 0.0021, two-tailed Student’s t-test, cx3cr1+/+
(n = 6) vs. cx3cr1−/− (n = 6)) while there was no difference in the Sirt1 signal when comparing cx3cr1+/− and cx3cr1+/+ microglia (p = 0.7641, two-tailed
Student’s t-test, cx3cr1+/+ (n = 6) vs. cx3cr1+/− (n = 5)). Bars represent the integrated fluorescence density of the Sirt1 signal in microglia of cx3cr1+/− and
cx3cr1−/− mice relative to the Sirt1 signal in DG cx3cr1+/+ microglia (b, bar graphs to the right). c Immunostaining for microglial acetylated p65 (red) in
the hippocampal DG (upper row) and CA1 region (lower row) of the same mouse strains revealed the strongest signals in the DG of cx3cr1+/−
(p = 0.0002, two-tailed Student’s t-test, cx3cr1+/+ (n = 6) vs. cx3cr1+/− (n = 5)) and cx3cr1−/− mice (p = 0.0001, two-tailed Student’s t-test, cx3cr1+/− (n = 5)
vs. cx3cr1−/− (n = 7)). There was only a mildly increased acp65 signal in CA1 microglia from cx3cr1−/− mice (p = 0.0149, two-tailed Student’s t-test, cx3cr1
+/+ (n = 5) vs. cx3cr1−/− (n = 6)). Signal intensity for microglial acp65 was indistinguishable in cx3cr1+/− and cx3cr1+/+ mice (p = 0.1555, two-tailed
Student’s t-test, cx3cr1+/+ (n = 5) vs. cx3cr1−/− (n = 5)) (c, bar graphs to the right). d Immunostaining for acp65 in cx3cr1−/− microglia was significantly
reduced in cx3cr1−/− mice pretreated with resveratrol (p < 0.001, two-tailed Student’s t-test, cx3cr1−/− + vehicle (n = 7) vs. cx3cr1−/− + resveratrol (n = 7))
and increased following EX527 treatment (p = 0.0002, two-tailed Student’s t-test, cx3cr1−/− + vehicle (n = 7) vs. cx3cr1−/− + EX527 (n = 7)).
One representative experiment of two is shown. Bars represent mean ± SEM; n.s., not significant. ***p < 0.001; **p < 0.01; *p < 0.05
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in the hippocampal CA1 area for all three genotypes.
Still, cx3cr1−/− microglia showed the most intense
SIRT1 signal when compared to microglia from het-
erozygous and wildtype littermates (Fig. 3b, lower
row). Interestingly, the elevated integrated fluores-
cence density of the SIRT1 signal in cx3cr1−/− micro-
glia was paralleled by a high signal intensity of
acetylated p65 (acp65) in cx3cr1−/− microglia within
the DG (Fig. 3c, upper row) and the CA1 region
(Fig. 3c, lower row), indicative of an active NF-kB
complex [46]. In both areas, the acp65 signal was di-
minished in microglia from cx3cr1+/− and cx3cr1+/+
mice and was overall less intense in microglia located
in the hippocampal CA1 region when compared to
DG microglia (Fig. 3c). When cx3cr1−/− mice were
treated with resveratrol, a SIRT1 activator [47], the
acp65 signal in microglia within the DG was reduced.
On the other hand, the acp65 signal in cx3cr1−/− mice
was amplified by treating the animals with EX527, a
selective inhibitor of SIRT1 [48] (Fig. 3d). Since cyto-
kines are largely induced through the NF-kB pathway
we isolated microglia via laser-microdissection from
the DG area (Fig. 4a) and found elevated level of
CXCL10, TNFα and IL-β mRNA in cx3cr1−/− micro-
glia while expression of CCL2 and CCL3 showed no
difference when compared to cx3cr1+/+ microglia
mRNA (Fig. 4b).
Activation of sirtuin 1 restores cognitive performance and
neurogenesis in cx3cr1−/− mice
With the help of a sirtuin 1 activity assay we could de-
termine that the elevated level of SIRT1 in hippocampal
cx3cr1−/− microglia resulted in increased SIRT1 activity
in comparison to SIRT1 activity in microglia from
cx3cr1+/+ hippocampi (Fig. 5c). In order to determine
whether modulation of SIRT1 activity affects the number
and proliferation of DCX+ cells in the DG, as indicated
by double-staining with the cell proliferation marker
Ki67, we treated cx3cr1−/− mice with either EX527 or
with resveratrol. While the treatment with EX527 fur-
ther reduced neuronal lineage proliferation and the
number of DCX+ cells when compared to vehicle-
treatment, activation of SIRT1 by resveratrol recovered
proliferation and the number of DCX+ cells in cx3cr1−/−
mice returned back to the situation found in cx3cr1+/+
mice (Fig. 5a, b). The SIRT1 activity assay showed that
EX527 efficiently reduced SIRT1 activity in hippocampal
microglia from cx3cr1−/− mice and that resveratrol acti-
vated SIRT1 even above the elevated SIRT1 activity
found in vehicle-treated cx3cr1−/− mice (Fig. 5c). To
study the impact of SIRT1 activity and changes in adult
neurogenesis on spatial learning and memory, animals
were subjected to the Morris Water Maze test. The
treatment of cx3cr1+/+ mice with EX527 had no effect
on either escape latency during the learning phase or
time spent in the target quadrant as an indicator of
memory (Fig. 5d, e). This finding suggests that SIRT1 ac-
tivity is not involved in spatial learning and memory
under baseline conditions. In contrast, cx3cr1−/− mice
showed impaired learning and memory when compared
to cx3cr1+/+ mice (Fig. 5d, e). This impairment became
even more prominent in cx3cr1−/− mice pretreated with
EX527 (Fig. 5d, e). cx3cr1+/+ and cx3cr1−/− mice showed
similar swim speed (Fig. 5h) and latency to find the vis-
ible platform (Fig. 5i) after pretreatment with vehicle
alone or in combination with EX527. Activation of
SIRT1 by injection of resveratrol improved spatial learn-
ing and memory in cx3cr1−/− mice up to the level dem-
onstrated by cx3cr1+/+ mice (Fig. 5f, g). Again, swim
Fig. 4 Increased cytokine expression in cx3cr1−/− microglia isolated from
DG. a CD11b positive cells were lasermicrodissected from the DG area
and RNA was isolated for real-time PCR. b RT-PCR experiments showed
that CCL2 (p= 0.354, two-tailed Student’s t-test, cx3cr1−/− (n= 5) vs.
cx3cr1+/+ (n= 4)) and CCL3 (p= 0.107, two-tailed Student’s t-test, cx3cr1
−/− (n= 5) vs. cx3cr1+/+ (n= 4)) expression was similar in microglial RNA
from cx3cr1+/+ and cx3cr1−/− mice. Significantly increased expression level
of CXCL10 (p= 0.013, two-tailed Student’s t-test, cx3cr1−/− (n= 5) vs.
cx3cr1+/+ (n= 4)), TNF-α (p= 0.0001, two-tailed Student’s t-test, cx3cr1−/−
(n= 5) vs. cx3cr1+/+ (n= 4)) and IL-1β (p= 0.0004, two-tailed Student’s t-
test, cx3cr1−/− (n= 5) vs. cx3cr1+/+ (n= 4)) mRNA were detected in cx3cr1
−/− mice. One representative experiment of two is shown. Bars represent
mean ± SEM; n.s., not significant. ***p< 0.001; *p< 0.05
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Fig. 5 Activation of microglial SIRT1 increases proliferation of DCX+ cells in cx3cr1−/− mice and improves spatial learning and memory. a
Immunohistochemistry in DG reveals cell nuclei stained with DAPI (blue), cells positive for the proliferation marker Ki67 (white) and positive for DCX
(red) in vehicle-treated cx3cr1+/+ (top, left) and cx3cr1−/− (bottom, left) mice and in cx3cr1−/− mice treated with EX527 (top, right) or resveratrol (bottom,
right). b Numbers of DCX+ (p = 0.0078, two-tailed Student’s t-test, cx3cr1+/+ + vehicle (n = 6) vs. cx3cr1−/− + vehicle (n = 6)) and DCX+/Ki67+ (p = 0.0003,
two-tailed Student’s t-test, cx3cr1+/+ + vehicle (n = 6) vs. cx3cr1−/− + vehicle (n = 6)) cells were reduced in cx3cr1−/− mice compared with cx3cr1+/+ mice.
Both groups were vehicle-treated. A further reduction of DCX+ (p = 0.0003, two-tailed Student’s t-test, cx3cr1−/− + vehicle (n = 6) vs. cx3cr1−/− + EX527
(n = 6)) and DCX+/Ki67+ (p = 0.0041, two-tailed Student’s t-test, cx3cr1−/− + vehicle (n = 6) vs. cx3cr1−/− + EX527 (n = 6)) cells occurred when cx3cr1−/−
mice were pretreated with EX527. There was no difference in cell numbers of DCX+ (p = 0.0597, two-tailed Student’s t-test, cx3cr1−/− + Resv. (n = 6))
and DCX+/Ki67+ (p = 0.184, two-tailed Student’s t-test, cx3cr1−/− + Resv. (n = 6)) cells in vehicle-treated cx3cr1+/+ and resveratrol-treated cx3cr1−/− mice.
c A sirtuin 1 activity assay using nuclear extracts from sorted microglia revealed significant differences between vehicle-treated cx3cr1+/+
(n = 6) and cx3cr1−/− mice (n = 6) (p = 0.0029, two-tailed Student’s t-test), vehicle-treated cx3cr1+/+ and resveratrol-treated cx3cr1+/+ mice
(n = 6) (p = 0.0013, two-tailed Student’s t-test), vehicle-treated cx3cr1−/− and EX527-treated cx3cr1−/− mice (n = 7) (p = 0.02, two-tailed Stu-
dent’s t-test) and between vehicle-treated cx3cr1−/− and resveratrol-treated cx3cr1−/− mice (n = 6) (p = 0.02, two-tailed Student’s t-test).d, f
Learning abilities as measured by escape latency to find the hidden platform over 6 days (two-way ANOVA followed by Bonferroni post
hoc, p < 0.05, F1,50 = 44.28, p < 0.0001, cx3cr1
+/+ + vehicle (n = 6) vs. cx3cr1−/− + EX527 (n = 7), F1,46 = 12,34, p = 0.001, cx3cr1
+/+ + vehicle
(n = 6) vs. cx3cr1−/− + vehicle (n = 6), F1,46 = 2.07, p = 0.1565, cx3cr1
+/+ + vehicle (n = 6) vs. cx3cr1+/+ + EX527 (n = 6). e, g Spatial memory
retention evaluated during the probe test performed 24 h later (two-tailed Student’s t-test, p = 0.0343, cx3cr1+/+ + vehicle (n = 6) vs.
cx3cr1−/− + vehicle (n = 6); p = 0.0119, cx3cr1−/− + vehicle (n = 6) vs. cx3cr1−/− + EX527 (n = 6); p = 0.0035, cx3cr1+/+ + vehicle (n = 6) vs. cx3cr1
−/− + EX527 (n = 6)), h,j swim speed during the learning phase and i, k latency to reach the visible platform of cx3cr1+/+ and cx3cr1−/−
pre-treated with either vehicle alone or with vehicle in combination with EX527 or resveratrol. One representative experiment of three is
shown. Bars represent mean ± SEM; n.s., not significant. Asterisks depict p value when compared to cx3cr1+/++ vehicle group. ***p < 0.001;
**p < 0.01; *p < 0.05
Sellner et al. Acta Neuropathologica Communications  (2016) 4:102 Page 9 of 13
speed and time to reach the visible platform were not af-
fected by the treatment indicating that mice were not
visually or motivationally impaired (Fig. 5j, k).
Discussion
With the present study we show that, under resting con-
ditions, SIRT1 and the NF-kB pathway are activated in
cx3cr1−/− microglia residing within the murine DG area.
This activation seems to be restricted to the DG and was
largely diminished in the hippocampal CA1 region. As a
result of pharmacological SIRT1 activation, impaired
adult neurogenesis and lowered hippocampal cognitive
performance was restored in cx3cr1−/− mice.
We hypothesize that the NF-kB signaling pathway and
SIRT1 enzyme in microglia interact to maintain cellular
homeostasis in vivo. Since the fractalkine receptor
CX3CR1 inhibits cAMP signaling including the cAMP-
dependent protein kinase A (PKA) via coupling to a Gi-
protein coupled receptor [43], deletion of CX3CR1 from
microglia might facilitate activation of PKA and subse-
quently NF-kB activation [49]. Stimuli causing PKA acti-
vation appear to be restricted to certain brain regions
with e.g. enhanced cellular turnover like the DG because
only marginal acp65 signals were detected outside the
DG as seen in the CA1 area. In response to increased
acetylation of p65 in cx3cr1−/− microglia, SIRT1 activity
is amplified, most likely to counteract excessive NF-kB
signaling. Activation of SIRT1 can induce deacetylation
of the RelA/p65 component of the NF-kB complex. The
deacetylation of Lys310 inhibits the transactivation cap-
acity of RelA/p65 subunit and consequently suppresses
the transcription of the NF-kB-dependent gene expres-
sion [20]. However, in cx3cr1−/− microglia SIRT1 activity,
although elevated, appears to be insufficient to prevent
NF-kB-dependent gene expression [50] as indicated by
elevated protein levels of IL-1β in the hippocampus [13]
or by increased CXCL10, TNF-α and IL-1β mRNA ex-
pression in microglia micro-dissected from DG of cx3cr1
−/− mice (Fig. 4). Only additional SIRT1 activation can
effectively counteract activation of the NF-kB pathway.
Interestingly, in wild-type mice where no microglial NF-
kB activation was detectable, activation of SIRT1 had no
effect on adult neurogenesis or performance in the water
maze test (data not shown). Previous studies have shown
that especially IL-1β can impair adult neurogenesis by
decreasing proliferation in the DG of cx3cr1−/− mice
[13]. A similar mechanism was observed in wild-type
mice under stressed conditions when elevated IL-1β re-
duced hippocampal neurogenesis and administration of
an IL-1 receptor antagonist restored the neurogenesis
rate following stress exposure [51]. Notably, despite the
pro-inflammatory activation status of cx3cr1−/− micro-
glia, no morphological changes could be detected in
comparison to cx3cr1+/+ microglia, confirming previous
findings within an independent set of experiments [52].
During development in the hippocampus, microglial
morphology seems to depend, at least partially, on the
fractalkine receptor considering that at P8 a small popu-
lation of cx3cr1−/+ cells was typified by a very large sur-
face area. This group of cells was absent in brains of
cx3cr1−/− mice [53]. However, one report based on im-
munohistochemistry indicates that under normal physio-
logical conditions genetic cx3cr1 deficiency is associated
with microglial alterations, including increased cell num-
ber and enlargement of the soma [54]. While the recep-
tor for CX3CL1, CX3CR1, is highly expressed on
microglia, CX3CL1 is constitutively expressed at high
levels on healthy neurons. CX3CL1 is expressed as a
transmembrane protein that can be cleaved in a soluble
form, consisting of the extracellular N-terminal chemo-
kine domain, by the activity of the lysosomal cysteine
protease cathepsin S (CatS) or by members of the disin-
tegrin and metalloproteinase (ADAM) family, ADAM-10
and ADAM-17 [55]. The anatomical expression of
CX3CL1 on neurons and CX3CR1 on microglia suggests
that neurons may maintain microglia in a surveilling/
ramified state through a repressive CX3CL1 signal [56].
From this point of view it is unexpected to find intact
proliferation of neural stem/progenitor cells and adult
neurogenesis in CX3CL1-deficient mice while the same
process is impaired in mice lacking CX3CR1. If binding
of CX3CL1 elicits a tonic inhibitory signal, which main-
tains microglia in a quiescent state, its absence should
result in activated or pro-inflammatory microglia with
negative impact on neurogenesis and neurodevelopment.
While there is a consensus among studies for a neuro-
protective role of CX3CL1 signaling in vitro, some in
vivo studies even suggest a neurotoxic role of CX3CL1
as seen in animal models for Alzheimer’s- and Parkin-
son’s disease. Here, CX3CL1 can act as a repressor of
microglial phagocytic activity and cause overall microglia
activation [57, 58]. A further remarkable mode of action
was observed in lung endothelial cells, which respond to
stimuli and produce CX3CL1. This leads to the endothe-
lial attachment of the subset mononuclear leukocytes
that express the sole CX3CL1 receptor, CX3CR1 [59].
Following a challenge with lipopolysaccharides (LPS),
cx3cl1−/− mice exhibit reduced expression of CX3CR1
and impaired NF-kB signaling in lung tissue when com-
pared to wt controls [60]. CX3CL1 is a molecule that
may have various activities, with either no, beneficial or
destructive potential, likely depending on the activation
state of its main target cells. In support of our findings
cx3cl1−/− mice do not have histologic abnormalities in
any major organs (including the brain), hematopoietic
lineages in blood and lymphoid tissue are essentially
normal, and they do not exhibit any overt behavioral ab-
normalities [21]. There is also the possibility of an
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alternative CX3CR1 ligand, which might act similar to
CX3CL1. In humans eotaxin-3/CC chemokine ligand 26
was recently reported to be a functional ligand for
CX3CR1 [61]; in mice, the CCL26 gene, however, may be
a pseudogene since no cDNA or expressed sequence tag
(EST) has been reported [62]. Similar to previous reports
we found that hippocampal neurogenesis was decreased
in mice that lack CX3CR1 [15]. These mice display
significant deficits in cognitive functions and LTP induc-
tion due to increased action of IL-1β [14]. There are two
reports indicating that cx3cr1−/− mice have improved
hippocampal cognitive abilities compared to wild-type
controls [15, 54] with either enhanced [54] or impaired
[15] generation of neuronal precursors. The reason for
this inconsistency is presently unclear.
Conclusions
Our findings indicate that in the SGZ of the DG area in
cx3cr1−/− mice the number of DCX+ cells is reduced, in-
dependent of the CX3CR1 ligand CX3CL1. Enhanced
microglial NF-kB-dependent gene expression in the DG
results in elevated levels of chemokines such as IL-1β
and consequently in the inhibition of neurogenesis and
spatial cognitive function. Manipulation of SIRT1 activ-
ity interferes with NF-kB signaling, adult neurogenesis
and ultimately hippocampal learning and memory.
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